Rituximab
- IV / SubcutRituximabMabthera
- Mechanism of Action
- A monoclonal antibody that targets CD20, a transmembrane protein on the surface of B cells, resulting in antibody-dependent and complement-dependent cytotoxicity.
Clinical Use
- Indications
- Adverse Effects